Approval · Notice of Compliance 27910 · 2022
IMVAMUNE: Notice of Compliance 27910
Issued April 4, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27910
- Date
- April 4, 2022
- Company
- Bavarian Nordic AsHellerup, Denmark
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New drug product manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMVAMUNE | Not yet assigned | — |
Medicinal ingredients
- MODIFIED VACCINIA VIRUS (ANKARA-BAVARIAN NORDIC) 50,000,000 UNIT per 0.5ML